Evidence map›Paper›PMID 35370232›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Two Cases of Thyrotoxicosis and Euglycemic Diabetic Ketoacidosis Under Sodium-glucose Transport Protein 2 Inhibitor Treatment.

Takuhei Hitsuwari, Yuya Tsurutani, Takahiro Yamane, Takashi Sunouchi, Hirofumi Horikoshi, Rei Hirose, Yoshitomo Hoshino, Satoshi Watanabe, Sho Katsuragawa, Jun Saitou

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Takuhei HitsuwariEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan.
Yuya TsurutaniEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan.
Takahiro YamaneEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan.
Takashi SunouchiEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan.
Hirofumi HorikoshiEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan.
Rei HiroseEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan.
Yoshitomo HoshinoEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan.
Satoshi WatanabeEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan.
Sho KatsuragawaEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan.
Jun SaitouEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan.
Yokohama Rosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyrotoxicosis and sodium-glucose transport protein 2 inhibitors (SGLT2is) are associated with the induction of euglycemic diabetic ketoacidosis (euDKA). We herein report two cases of euDKA in patients with diabetes mellitus wherein both thyrotoxicosis and SGLT2i treatment were the underlying causes. One patient developed thyrotoxicosis during the course of type 2 diabetes mellitus, whereas the other patient was suspected of developing slowly progressive insulin-dependent diabetes mellitus during the course of Graves' disease. Although such cases are rare, there is some concern that similar cases may occur because of the increased frequency of SGLT2i use in recent years.

Indexed as

Diabetes Mellitus, Type 2Diabetic KetoacidosisGraves DiseaseSodium-Glucose Transporter 2 InhibitorsThyrotoxicosisHumansSodium-Glucose Transport ProteinsSodium-Glucose Transporter 2 InhibitorsSodium-Glucose Transport Proteinseuglycemic diabetic ketoacidosisGraves' diseaseSGLT2 inhibitorthyroid stormthyrotoxicosis

Identifiers

PMID35370232
PMCPMC9646346
OpenAlexW4225939211

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.